• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生殖细胞睾丸癌患者预后列线图的建立与验证。

Development and validation of prognostic nomogram for germ cell testicular cancer patients.

机构信息

Department of Urology, People’s Hospital of Putuo, Shanghai 200060, China.

Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China.

出版信息

Aging (Albany NY). 2020 Nov 2;12(21):22095-22111. doi: 10.18632/aging.104063.

DOI:10.18632/aging.104063
PMID:33136554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7695357/
Abstract

The purpose of our study was to establish a reliable and practical nomogram based on significant clinical factors to predict the overall survival (OS) and cancer-specific survival (CSS) of patients with germ cell testicular cancer (GCTC). Patients diagnosed with GCTC between 2004 and 2015 were obtained from the SEER database. Nomograms were constructed using the R software to predict the OS and CSS probabilities and the constructed nomograms were validated and calibrated. A total of 22,165 GCTC patients were enrolled in the study, including the training cohort (15,515 patients) and the validation cohort (6,650 patients). In the training cohort, multivariate Cox regression showed that age, race, AJCC stage, SEER stage and surgery were independent prognostic factors for OS, while age, race, AJCC stage, TM stage, SEER stage and radiotherapy were independent prognostic factors for CSS. Based on the above Cox regression results, we constructed prognostic nomograms of OS and CSS in GCTC patients and found that the OS nomograms had higher C-index and AUC compared to TNM stage in the training and validation cohorts. In addition, in the training and external validation cohorts, the calibration curves showed a good consistency between the predicted and actual 3-, 5- and 10-year OS and CSS rates of the nomogram. The current prognostic nomogram can provide a personalized risk assessment for the survival of GCTC patients.

摘要

我们的研究目的是基于重要的临床因素建立一个可靠且实用的列线图,以预测生殖细胞睾丸癌(GCTC)患者的总生存(OS)和癌症特异性生存(CSS)。从 SEER 数据库中获取了 2004 年至 2015 年间诊断为 GCTC 的患者。使用 R 软件构建列线图以预测 OS 和 CSS 概率,并验证和校准构建的列线图。共有 22,165 名 GCTC 患者纳入研究,包括训练队列(15,515 名患者)和验证队列(6,650 名患者)。在训练队列中,多变量 Cox 回归显示年龄、种族、AJCC 分期、SEER 分期和手术是 OS 的独立预后因素,而年龄、种族、AJCC 分期、TM 分期、SEER 分期和放疗是 CSS 的独立预后因素。基于上述 Cox 回归结果,我们构建了 GCTC 患者 OS 和 CSS 的预后列线图,发现 OS 列线图在训练和验证队列中的 C 指数和 AUC 均高于 TNM 分期。此外,在训练和外部验证队列中,校准曲线显示列线图预测的和实际的 3、5 和 10 年 OS 和 CSS 率之间具有良好的一致性。目前的预后列线图可为 GCTC 患者的生存提供个性化风险评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/35060ce8f841/aging-12-104063-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/57b6d4f319b0/aging-12-104063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/6890ccccd571/aging-12-104063-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/26b55beae1a5/aging-12-104063-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/2b607eef2884/aging-12-104063-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/4044b430bc1e/aging-12-104063-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/35060ce8f841/aging-12-104063-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/57b6d4f319b0/aging-12-104063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/6890ccccd571/aging-12-104063-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/26b55beae1a5/aging-12-104063-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/2b607eef2884/aging-12-104063-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/4044b430bc1e/aging-12-104063-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/7695357/35060ce8f841/aging-12-104063-g006.jpg

相似文献

1
Development and validation of prognostic nomogram for germ cell testicular cancer patients.生殖细胞睾丸癌患者预后列线图的建立与验证。
Aging (Albany NY). 2020 Nov 2;12(21):22095-22111. doi: 10.18632/aging.104063.
2
A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.基于 SEER 的列线图能准确预测尤文肉瘤的预后。
Sci Rep. 2021 Nov 22;11(1):22723. doi: 10.1038/s41598-021-02134-0.
3
Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.开发和验证一个列线图模型以预测胃贲门癌患者的预后。
Sci Rep. 2020 Aug 24;10(1):14143. doi: 10.1038/s41598-020-71146-z.
4
A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.胃印戒细胞癌患者的预后模型。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211027912. doi: 10.1177/15330338211027912.
5
A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.卵巢黏液性囊腺癌患者的预后模型:基于人群的分析。
J Ovarian Res. 2022 Feb 16;15(1):26. doi: 10.1186/s13048-022-00958-6.
6
Development and validation of a prognostic nomogram for adult patients with renal sarcoma: A retrospective study based on the SEER database.基于 SEER 数据库的回顾性研究:建立和验证用于预测成人肾肉瘤患者预后的列线图
Front Public Health. 2022 Sep 12;10:942608. doi: 10.3389/fpubh.2022.942608. eCollection 2022.
7
A nomogram for predicting survival and retroperitoneal lymph node dissection treatment in patients with resected testicular germ cell tumors.用于预测接受根治性睾丸生殖细胞肿瘤切除术患者的生存和腹膜后淋巴结清扫术治疗的列线图。
J Surg Oncol. 2019 Sep;120(3):508-517. doi: 10.1002/jso.25519. Epub 2019 May 29.
8
Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.列线图预测 IIIC1 期宫颈癌患者的总生存和癌症特异性生存。
BMC Cancer. 2021 Apr 23;21(1):450. doi: 10.1186/s12885-021-08209-5.
9
The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.基于 SEER 数据库的人群研究:用于预测老年早期肺癌患者总生存和癌症特异生存的列线图。
Front Public Health. 2022 Sep 8;10:946299. doi: 10.3389/fpubh.2022.946299. eCollection 2022.
10
Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.预测 I-III 期老年结肠癌患者癌症特异性生存的列线图。
Scand J Gastroenterol. 2020 Feb;55(2):202-208. doi: 10.1080/00365521.2020.1720280. Epub 2020 Feb 1.

引用本文的文献

1
Comparing oncologic outcomes of partial and radical nephrectomy for T2 renal cell carcinoma: a propensity score matching cohort study and an external multicenter validation.比较T2期肾细胞癌部分肾切除术和根治性肾切除术的肿瘤学结局:一项倾向评分匹配队列研究及外部多中心验证
World J Urol. 2025 Mar 12;43(1):166. doi: 10.1007/s00345-025-05561-0.
2
Development and validation of a prognostic nomogram for patients with ganglioneuroblastoma: A SEER-based study.神经节神经母细胞瘤患者预后列线图的开发与验证:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Heliyon. 2024 May 8;10(9):e30891. doi: 10.1016/j.heliyon.2024.e30891. eCollection 2024 May 15.
3

本文引用的文献

1
Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.用于预测肾癌患者总生存期和癌症特异性生存期的预后列线图及Aggtrmmns评分系统。 需注意,原文中的“Aggtrmmns”可能有误,不太明确其准确含义。
Cancer Med. 2020 Apr;9(8):2710-2722. doi: 10.1002/cam4.2916. Epub 2020 Feb 22.
2
Construction of a nomogram to predict overall survival for patients with M1 stage of colorectal cancer: A retrospective cohort study.构建预测结直肠癌 M1 期患者总生存期的列线图:一项回顾性队列研究。
Int J Surg. 2019 Dec;72:96-101. doi: 10.1016/j.ijsu.2019.10.021. Epub 2019 Oct 31.
3
Development and validation of a nomogram to predict lung metastasis in patients with testicular germ cell tumors.
预测睾丸生殖细胞肿瘤患者肺转移的列线图的开发与验证
Heliyon. 2023 Sep 16;9(9):e20177. doi: 10.1016/j.heliyon.2023.e20177. eCollection 2023 Sep.
4
Development and Validation of Prognostic Nomograms for Lung Squamous Cell Carcinoma With Brain Metastasis in Patients Aged 45 Years or Older: A Population-Based Study.45 岁及以上肺鳞癌脑转移患者预后列线图的建立与验证:基于人群的研究。
Cancer Control. 2023 Jan-Dec;30:10732748231202953. doi: 10.1177/10732748231202953.
5
Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls.睾丸生殖细胞肿瘤患者与年龄匹配的基于人群的男性对照者未来预期寿命的差异。
Int Urol Nephrol. 2023 Dec;55(12):3119-3128. doi: 10.1007/s11255-023-03763-2. Epub 2023 Aug 28.
6
Construction of the XGBoost model for early lung cancer prediction based on metabolic indices.基于代谢指标的早期肺癌预测 XGBoost 模型的构建。
BMC Med Inform Decis Mak. 2023 Jun 13;23(1):107. doi: 10.1186/s12911-023-02171-x.
7
Clinical features and prognostic factors in patients diagnosed with lymphovascular invasion of testicular germ-cell tumors: Analysis based on the SEER database.睾丸生殖细胞肿瘤伴淋巴管侵犯患者的临床特征及预后因素:基于监测、流行病学和最终结果(SEER)数据库的分析
Front Oncol. 2023 Mar 3;13:1142441. doi: 10.3389/fonc.2023.1142441. eCollection 2023.
8
Characteristics of lung metastasis in testicular cancer: A large-scale population analysis based on propensity score matching.睾丸癌肺转移的特征:基于倾向评分匹配的大规模人群分析。
Front Surg. 2022 Nov 4;9:959573. doi: 10.3389/fsurg.2022.959573. eCollection 2022.
9
Identification of prognostic factors for predicting survival of patients with malignant adrenal tumors: A population-based study.预测恶性肾上腺肿瘤患者生存的预后因素识别:一项基于人群的研究。
Front Oncol. 2022 Oct 17;12:930473. doi: 10.3389/fonc.2022.930473. eCollection 2022.
10
A Population-Based Study: How to Identify High-Risk T1-2 Esophageal Cancer Patients?一项基于人群的研究:如何识别高危T1-2期食管癌患者?
Front Oncol. 2021 Dec 13;11:766181. doi: 10.3389/fonc.2021.766181. eCollection 2021.
Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer.
基于监测、流行病学和最终结果(SEER)数据库的骨转移性前列腺癌患者预后列线图的开发与验证
Medicine (Baltimore). 2019 Sep;98(39):e17197. doi: 10.1097/MD.0000000000017197.
4
Marital Status and Survival in Patients with Penile Cancer.阴茎癌患者的婚姻状况与生存情况
J Cancer. 2019 Jun 2;10(12):2661-2669. doi: 10.7150/jca.32037. eCollection 2019.
5
Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma.预测透明细胞肾细胞癌患者长期总生存和疾病特异性生存的列线图。
Onco Targets Ther. 2018 Sep 6;11:5535-5544. doi: 10.2147/OTT.S171881. eCollection 2018.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
A New Metastatic Lymph Node Classification-based Survival Predicting Model in Patients With Small Bowel Adenocarcinoma: A Derivation and Validation Study.一种基于新型转移淋巴结分类的预测小细胞腺癌患者生存模型:一项推导和验证研究。
EBioMedicine. 2018 Jun;32:134-141. doi: 10.1016/j.ebiom.2018.05.022. Epub 2018 Jun 13.
8
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.第八版 AJCC 癌症分期手册:继续从基于人群的方法向更“个体化”的癌症分期方法构建桥梁。
CA Cancer J Clin. 2017 Mar;67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17.
9
Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.机器人辅助腹膜后淋巴结清扫术治疗非精原细胞瘤性生殖细胞睾丸癌的安全性和早期肿瘤学效果。
Eur Urol. 2017 Mar;71(3):476-482. doi: 10.1016/j.eururo.2016.05.017. Epub 2016 May 24.
10
Testicular cancer--discoveries and updates.睾丸癌——发现与进展
N Engl J Med. 2014 Nov 20;371(21):2005-16. doi: 10.1056/NEJMra1407550.